home company antimicrobial resistance products news careers contact us

Executive Management

Nora Kaarela, M.Sc. (Med.Eng.), MBA (IMD), CEO

Petri Priha, Lic.Sc. (Tech.), Director of Quality and Production.

Konstantin Gurbanov, M.D.,PhD, docent, Medical Director

Ulla Vepsä, Director of Finance and Business Control

Board of Directors

Mr Göran Pettersson, G. Pettersson & Partners Ab, Chairman of Board

Dr Björn Appelberg, Head of Psychiatry / Hospital District of Helsinki and Uusimaa HUS

Dr René R. Kuijten, General Partner / Life Sciences Partners

Ms Maarit Säynevirta, Investment Director (Sitra Ventures) / Finnish National Fund for Research and Development SITRA

Mr Ulf Tossman, Investment Director / InnovationsKapital

Mr Keijo Väkiparta, Investment Director, Partner / Bio Fund Management Ltd

Personnel

The Company has currently 32 employees.

In addition, collaboration with the University of Helsinki and Louis Stokes Cleveland VA Medical Center.

Printer friendly version

 


Executive Management

Scientific Advisory Board

Background facts

Market outlook